DISCOUNT OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000ME15861

Real-time Bid/Ask 17:04:33 10/05/2024 BST
0.3 EUR / 0.36 EUR +37.50% Intraday chart for DISCOUNT OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-33.33%
1 month-14.29%
Date Price Change Volume
10/05/24 0.33 +37.50% 0
09/05/24 0.24 0.00% 0
08/05/24 0.24 +9.59% 0
07/05/24 0.219 -37.43% 0
06/05/24 0.35 +2.94% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 02:19 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer Morgan Stanley
WKN ME1586
ISINDE000ME15861
Date issued 26/09/2023
Strike 52
Maturity 20/09/2024 (133 Days)
Parity 1 : 1
Emission price 0.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.13
Lowest since issue 0.2
Spread 0.06
Spread %16.67%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.78 EUR
Average target price
39.45 EUR
Spread / Average Target
+1.73%
Consensus